SKI Market

Indian Indices

Sensex

83,580.40 266.47
( 0.32%)

Global Indices

Nasdaq

50,145.69 1,215.96
(2.49%)

Dow Jones

6,954.50 135.10
(1.98%)

Hang Seng

54,176.23 358.19
(0.67%)

Nikkei 225

10,359.93 50.71
(0.49%)

Forex

USD-INR

90.32 -0.07
(-0.08%)

EUR-INR

106.52 -0.28
(-0.26%)

GBP-INR

122.68 -1.05
(-0.85%)

JPY-INR

0.58 0.00
(-0.33%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

344.5797109

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

43.41

7962.8

EPS(TTM)

Face Value()

Div & Yield %

19.9

0.46

Back

Board of Accelya Solutions India recommends Interim Dividend

Jan 29,2026

Accelya Solutions India announced that the Board of Directors of the Company at its meeting held on 29 January 2026, has recommended a Interim Dividend of Rs.45 per share (i.e.450%), subject to the approval of the shareholders.

83,580.40 266.47 ( 0.32%)

50,145.69 1,215.96 (2.49%)

6,954.50 135.10 (1.98%)

54,176.23 358.19 (0.67%)

10,359.93 50.71 (0.49%)

90.32 -0.07 (-0.08%)

106.52 -0.28 (-0.26%)

122.68 -1.05 (-0.85%)

0.58 0.00 (-0.33%)